Performance of Parkinson´s disease cognitive scale rating scale (PD-CRS) after 2 years Subthalamic nucleus deep brain stimulation. Comparison with Mattis Dementia Rating Scale (MDRS) and Mini-Mental State Examination (MMSE)
Objective: To study the performance of PD-CRS before and 2 years after STN-DBS and compare their results with other recognized cognitive scales. Background: Parkinson´s disease…Diagnostic Utility of I123-FP-CIT Single Photon Emission Computed Tomography for Patients with Clinically Uncertain Parkinsonian Syndrome
Objective: This study investigated the impact of I123-FP-CIT single photon emission computed tomography (SPECT) for the diagnosis of patients with clinically uncertain parkinsonian syndrome (CUPS)…DNA methylation differs between idiopathic Parkinson Disease and Healthy Control subjects in the Parkinson’s Progression Marker Initiative (PPMI) cohort
Objective: Compare baseline whole blood DNA methylation in unmedicated idiopathic Parkinson's Disease (iPD) and healthy control (HC) participants from PPMI Background: Epigenetic mechanisms like DNA…Longitudinal Exercise is Associated with Reduced Hospitalization Risk in Parkinson’s Disease
Objective: To determine if longitudinal exercise and physical therapy (PT) use is associated with reduced risk of hospital encounter in individuals with Parkinson’s disease (iwPD).…Profiling the biochemical lysosomal activities in blood of patients with LRRK2 G2019S associated Parkinson’s disease
Objective: To replicate the previous study of Alcalay and coauthors on estimation of lysosomal enzymes activities [1] with additional estimation of corresponding substrates in patients…A modified Delphi panel to establish a threshold of meaningful progression on MDS-UPDRS Part III
Objective: To establish a threshold for meaningful progression on MDS-UPDRS Part III in an early-stage Parkinson's disease (PD) population (Hoehn & Yahr [H&Y] Stage I–II)…Brain effects of high-intensity exercise on the dopamine system in individuals with Parkinson’s disease
Objective: We used PET imaging with 18F-FE-PE2I to quantify dopamine transporter availability and neuromelanin (NM)-MRI to measure the NM content in the substantia nigra (SN)…Real-world evidence and feasibility of telemedicine for Parkinson’s disease
Objective: This work aims to provide real-world evidence for the feasibility of telemedicine in Parkinson’s disease (PD). Adherence data presented pertain to patients paying out…Changes in gait and mobility measures collected in daily living conditions, in different stages of Parkinson’s disease
Objective: To explore mobility measures collected in daily-living conditions in different stages of PD. Background: Gait and mobility impairments are considered a cardinal sign in…IMPACT OF DEEP BRAIN STIMULATION ELECTRODE POSITION ON GAIT IN PATIENTS WITH PARKINSON’S DISEASE
Objective: The aim of our study is to evaluate the impact of the deep brain stimulation (DBS) electrode position within the subthalamic nucleus on gait…
- « Previous Page
- 1
- …
- 293
- 294
- 295
- 296
- 297
- …
- 436
- Next Page »